Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Kim W, Kim JS, Rha SW, Choi BG, Jang WY, Kang DO, Park Y, Choi JY, Roh SY, Na JO, Choi CU, Kim EJ, Park CG, Seo HS, Choi SY, Byun JK, Cha J, Oh DJ, Jeong MH; other Korea Acute Myocardial Infarction Registry (KAMIR) investigators.
Kim W, et al.
Heart Vessels. 2020 Sep;35(9):1181-1192. doi: 10.1007/s00380-020-01598-w. Epub 2020 Apr 8.
Heart Vessels. 2020.
PMID: 32270356